⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Respiratory Syncytial Virus Vaccine Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
GSK
MRNA
AZN
Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
businesswire.com
PFE
China sets priorities for 2026 and beyond at the Two Sessions
prnewswire.com
WMT
COST
MCD
SBUX
AMZN
BABA
JD
NKE
GM
F
TSLA
NVDA
INTC
MSFT
GOOGL
AAPL
PFE
JNJ
MRK
Telescope Innovations Installs Second Self-Driving Lab at Pfizer Ready to Announce with Confidence?
newsfilecorp.com
PFE
Global Times: A target of seeking progress while maintaining stability, being proactive and pragmatic
prnewswire.com
LUV
XPEV
LI
NIO
PLUG
SEDG
ENPH
DQ
JKS
BE
FCEL
RUN
FSLR
BABA
JD
PDD
BYDDY
TSLA
GM
F
RIVN
LCID
NVDA
AMD
INTC
MU
AMAT
LRCX
KLAC
ASML
SMCI
MSFT
GOOGL
AMZN
IBM
ORCL
CRM
ADBE
PYPL
COIN
UPST
SOFI
AXP
V
MA
GS
JPM
MS
BAC
WFC
CMCSA
VZ
T
NFLX
DIS
CMG
MCD
SBUX
YUM
PEP
KO
PG
JNJ
PFE
MRK
BMY
LLY
ABBV
GILD
AMGN
BIIB
REGN
VRTX
MRNA
BNTX
AZN
NVO
SNY
XOM
CVX
SHEL
BZUN
VIPS
QCOM
MRVL
NXPI
ON
ADI
MCHP
AVGO
QGEN
ILMN
EXAS
MDLZ
KDP
GIS
KHC
CL
EL
NKE
UA
LULU
CPRI
PVH
M
TJX
ROST
BBY
HD
LOW
COST
WMT
TGT
KR
LVS
MGM
WYNN
CCL
RCL
NCLH
DAL
UAL
AAL
BA
GD
LMT
RTX
GE
HON
CAT
DE
MMM
DOW
DD
ECL
IFF
ADM
CF
MOS
NTR
BHP
RIO
VALE
AA
FCX
STLD
NUE
CFG
KEY
USB
PNC
BBT
STI
BBVA
HSBC
SCHW
RJF
SYF
CINF
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
prnewswire.com
GSK
UPB
SNY
LLY
AZN
AMGN
REGN
PFE
MRK
TEVA
NVS
INSM
LYRA
North American Dietary Supplements Market Poised to Add USD 90.4B by 2036 - Future Market Insights (FMI)
prnewswire.com
HLF
ABT
PFE
KMB
USNA
Proxima Appoints Dr. Raymond Deshaies, Dr. Lyn Jones, and Dr. Juri Rappsilber to Scientific Advisory Board
businesswire.com
AMGN
PFE
JNJ
Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
prnewswire.com
BIIB
IONS
ALNY
AZN
GILD
JNJ
BMRN
VRTX
ASTL
PFE
NVO
REGN
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
globenewswire.com
PFE